USE OF MONOCLONAL ANTIBODIES AGAINST THE EPIDERMAL GROWTH FACTOR RECEPTOR IN THE TREATMENT OF PATIENTS WITH ACUTE HYPOXAEMIC RESPIRATORY FAILURE

The present invention relates to the fields of biotechnology and medicine. The invention relates to the use of monoclonal antibodies directed against the epidermal growth factor receptor in the treatment of diseases of infectious origin where acute hypoxaemic respiratory failure occurs. La presente...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	JIMÉNEZ ARMADA Jorge, LEÓN MONZÓN Kalet, ABDO CUZA Anselmo Antonio, RAMOS SUZARTE Mayra, CROMBET RAMOS Tania, AÑÉ KOURÍ Ana Laura, SAAVEDRA HERNÁNDEZ Danay, PÉREZ RODRÍGUEZ Rolando, DÍAZ LONDRES Henrry
Format:	Patent
Sprache:	eng ; spa
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to the fields of biotechnology and medicine. The invention relates to the use of monoclonal antibodies directed against the epidermal growth factor receptor in the treatment of diseases of infectious origin where acute hypoxaemic respiratory failure occurs. La presente invención se relaciona con las ramas de la Biotecnología y la Medicina. Se describe el uso de anticuerpos monoclonales dirigidos contra el receptor del factor de crecimiento epidérmico en el tratamiento de enfermedades de origen infeccioso donde se produce una insuficiencia respiratoria aguda hipoxémica.